RIPK1 INHIBITORS AND METHODS OF USE

Described herein are compounds of Formula II, or a pharmaceutically acceptable salt thereof. The compounds of Formula I act as RIPK1 inhibitors and can be useful in preventing, treating or acting as a remedial agent for RIPK1-related diseases.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Fuller, Peter H, Lu, Min, Mitcheltree, Matthew J, Su, Jing, DiMauro, Erin F, Methot, Joey L, Fradera, Xavier, Musacchio, Andrew J, Siliphaivanh, Phieng
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Described herein are compounds of Formula II, or a pharmaceutically acceptable salt thereof. The compounds of Formula I act as RIPK1 inhibitors and can be useful in preventing, treating or acting as a remedial agent for RIPK1-related diseases.